There are 2934 resources available
4800 - Plasma proteomics in patients with metastatic cutaneous melanoma treated with immune checkpoint inhibitors
Presenter: Hanna Eriksson
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
3790 - Tumor size and overall survival in a cohort of young (_40 years), node negative, systemically untreated breast cancer patients; by the PARADIGM study group.
Presenter: Vincent De Jong
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
4332 - Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC)
Presenter: Jenny Furlanetto
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
1375 - Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments – a population-based study
Presenter: Nienke De Glas
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
4042 - Utility of the CPS+EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy
Presenter: Frederik Marmé
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
4001 - Neoadjuvant endocrine therapy with palbociclib in patients with high-risk breast cancer
Presenter: Per Eystein Lønning
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
3933 - Neoadjuvant olaparib monotherapy in primary triple negative breast cancer
Presenter: Hans Eikesdal
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
1804 - Immunological differences between immune-rich estrogen receptor-positive and -negative breast cancers
Presenter: Tess O'Meara
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
4132 - Prospective, multicenter registry trial to evaluate the clinical feasibility of targeted axillary dissection (TAD) in patients (pts) with breast cancer (BC) and core biopsy proven axillary involvement (cN+)
Presenter: Mattea Reinisch
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract
5429 - Long-term results of the PACS 04 trial evaluating adjuvant Epirubicin plus Docetaxel in node-positive breast cancer and Trastuzumab in the HER2-positive subgroup
Presenter: Veronique D'Hondt
Session: Poster Discussion - Breast cancer, early stage
Resources:
Abstract